Antimicrobial Resistance: India’s Silent Public Health Emergency

Antimicrobial resistance — the phenomenon by which bacteria and other pathogens evolve resistance to the antibiotics historically used to treat them — represents a public health threat that global health authorities have described in increasingly urgent terms, and India occupies a particularly significant position within this global challenge, both as a country experiencing some of the highest documented rates of antimicrobial resistance for several common bacterial infections, and as a major global manufacturer of the antibiotics whose overuse partly drives the resistance problem worldwide.

The Scale of the Problem in India

Clinical surveillance data from Indian hospitals has documented resistance rates for several common bacterial pathogens, including resistance to last-resort antibiotic classes, at levels that infectious disease specialists describe as among the most concerning globally, a pattern with direct clinical consequences: infections that would have been readily treatable with standard antibiotic courses a generation ago increasingly require more expensive, more toxic, or simply less effective alternative treatments, with measurably worse patient outcomes in documented clinical studies.

The Dual Drivers: Healthcare and Agriculture

India’s antimicrobial resistance challenge is driven by overuse in two distinct but interconnected domains. Within healthcare, widespread availability of antibiotics without prescription requirements in many pharmacy settings, combined with frequent inappropriate prescribing for viral infections that antibiotics cannot treat, has driven antibiotic consumption to levels considerably higher than clinical need would justify. Within agriculture, the use of antibiotics in livestock farming, partly for disease prevention in crowded farming conditions rather than only for treating active infection, has been identified by researchers as a significant additional contributor to the broader resistance burden, since resistant bacteria that develop in agricultural settings can transfer to human populations through multiple documented pathways.

A health threat that develops gradually, through the accumulated effect of millions of individual antibiotic doses rather than any single dramatic event, struggles to command the same policy urgency as more visible health emergencies, even when its eventual mortality toll, as documented in peer-reviewed research, is considerable.

The Policy Response and Its Gaps

India has implemented a National Action Plan on antimicrobial resistance, including provisions intended to restrict over-the-counter antibiotic sales and improve antibiotic stewardship within hospital settings, alongside surveillance systems intended to track resistance patterns more systematically. Implementation of prescription requirement enforcement, however, has been inconsistent, with many pharmacies continuing to dispense antibiotics without prescription in practice despite the formal regulatory requirement, reflecting a broader enforcement capacity gap that affects multiple areas of Indian healthcare regulation beyond antimicrobial resistance specifically.

What a More Adequate Response Would Require

Closing the gap between India’s stated antimicrobial resistance policy and its actual on-the-ground enforcement would require considerably strengthened pharmacy regulation enforcement capacity, sustained public health communication addressing patient expectations around antibiotic prescribing for conditions antibiotics cannot effectively treat, and continued investment in domestic research and development of new antibiotic compounds, an area where global pharmaceutical industry investment has lagged considerably behind the scale of the resistance threat due to the limited commercial profitability of antibiotics relative to other drug categories. India’s scientific and clinical research community has produced some of the most rigorous documentation of this threat’s scale. Translating that documentation into commensurate policy enforcement and public health behaviour change remains the considerably harder unfinished task.